Md. Asad Ullah

994 total citations
45 papers, 540 citations indexed

About

Md. Asad Ullah is a scholar working on Molecular Biology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Md. Asad Ullah has authored 45 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Infectious Diseases and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Md. Asad Ullah's work include vaccines and immunoinformatics approaches (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (8 papers). Md. Asad Ullah is often cited by papers focused on vaccines and immunoinformatics approaches (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (8 papers). Md. Asad Ullah collaborates with scholars based in Bangladesh, India and Canada. Md. Asad Ullah's co-authors include Bishajit Sarkar, Yusha Araf, Abu Tayab Moin, Mohammad Jakir Hosen, Tanjim Ishraq Rahaman, Mohammad Shahedur Rahman, MD. Hasanur Rahman, Chunfu Zheng, Rajesh B. Patil and Masuma Afrin Taniya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Md. Asad Ullah

43 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Md. Asad Ullah Bangladesh 15 279 180 103 101 84 45 540
Bishajit Sarkar Bangladesh 15 336 1.2× 161 0.9× 78 0.8× 100 1.0× 92 1.1× 37 565
Vimal K. Maurya India 12 250 0.9× 424 2.4× 108 1.0× 77 0.8× 37 0.4× 26 877
Swatantra Kumar India 10 224 0.8× 406 2.3× 117 1.1× 71 0.7× 34 0.4× 24 831
Abu Tayab Moin Bangladesh 12 185 0.7× 109 0.6× 96 0.9× 73 0.7× 59 0.7× 34 427
Maochen Li China 9 156 0.6× 338 1.9× 69 0.7× 58 0.6× 53 0.6× 21 597
Mohammad A. I. Al-Hatamleh Malaysia 14 166 0.6× 337 1.9× 99 1.0× 65 0.6× 27 0.3× 38 922
Nicole Restrepo United States 11 343 1.2× 154 0.9× 75 0.7× 133 1.3× 33 0.4× 17 874
Md Sorwer Alam Parvez Bangladesh 10 178 0.6× 473 2.6× 70 0.7× 50 0.5× 49 0.6× 16 744
Priyanka Shah India 17 265 0.9× 122 0.7× 79 0.8× 47 0.5× 50 0.6× 35 698

Countries citing papers authored by Md. Asad Ullah

Since Specialization
Citations

This map shows the geographic impact of Md. Asad Ullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Asad Ullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Asad Ullah more than expected).

Fields of papers citing papers by Md. Asad Ullah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md. Asad Ullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Asad Ullah. The network helps show where Md. Asad Ullah may publish in the future.

Co-authorship network of co-authors of Md. Asad Ullah

This figure shows the co-authorship network connecting the top 25 collaborators of Md. Asad Ullah. A scholar is included among the top collaborators of Md. Asad Ullah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md. Asad Ullah. Md. Asad Ullah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Masood, et al.. (2024). CLINICAL FEATURES AND MANAGEMENT OF TETANUS. 3(1). 19–24.
2.
Moin, Abu Tayab, et al.. (2024). In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses. PLoS ONE. 19(5). e0300778–e0300778. 8 indexed citations
3.
Moin, Abu Tayab, Md. Asad Ullah, Rajesh B. Patil, et al.. (2023). A computational approach to design a polyvalent vaccine against human respiratory syncytial virus. Scientific Reports. 13(1). 9702–9702. 14 indexed citations
4.
Ullah, Md. Asad, et al.. (2023). Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients. Computers in Biology and Medicine. 158. 106855–106855. 1 indexed citations
5.
Ullah, Md. Asad, et al.. (2022). Expression analysis, molecular characterization and prognostic evaluation on TMED4 and TMED9 gene expression in glioma. Biomedical Signal Processing and Control. 78. 103922–103922. 2 indexed citations
6.
Araf, Yusha, et al.. (2022). Functional food: complementary to fight against COVID-19. Beni-Suef University Journal of Basic and Applied Sciences. 11(1). 33–33. 33 indexed citations
8.
Ullah, Md. Asad, et al.. (2022). COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies. Current Microbiology. 79(5). 127–127. 42 indexed citations
10.
Araf, Yusha, Abu Tayab Moin, В. И. Тимофеев, et al.. (2022). Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi. Frontiers in Immunology. 13. 863234–863234. 35 indexed citations
11.
Moin, Abu Tayab, et al.. (2022). Computational designing of a novel subunit vaccine for human cytomegalovirus by employing the immunoinformatics framework. Journal of Biomolecular Structure and Dynamics. 41(3). 833–855. 8 indexed citations
12.
Ullah, Md. Asad, et al.. (2021). Gut Microorganisms and Neurological Disease Perspectives. Future Neurology. 16(1). 13 indexed citations
13.
Islam, Md. Saiful, Md. Asad Ullah, Sahadat Hossain, et al.. (2021). Influence on attitudes and lifestyle due to lockdown amidst COVID-19 pandemic: a perception-based analysis among Bangladeshi residents. BMC Public Health. 21(1). 1974–1974. 4 indexed citations
15.
Sarkar, Bishajit, et al.. (2021). Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh. Microbiology Resource Announcements. 10(27). e0051121–e0051121. 4 indexed citations
16.
Sarkar, Bishajit, Md. Asad Ullah, Yusha Araf, & Mohammad Shahedur Rahman. (2020). Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach. Informatics in Medicine Unlocked. 21. 100478–100478. 23 indexed citations
17.
Anwar, Saeed, Yusha Araf, Md. Asad Ullah, et al.. (2020). Women's Knowledge, Attitude, and Perceptions Toward COVID-19 in Lower-Middle-Income Countries: A Representative Cross-Sectional Study in Bangladesh. Frontiers in Public Health. 8. 571689–571689. 19 indexed citations
18.
Sarkar, Bishajit, et al.. (2019). Virus like particles- A recent advancement in vaccine development. 55(4). 327–343. 15 indexed citations
19.
Sarkar, Bishajit, et al.. (2019). Anticancer potential of medicinal plants from Bangladesh and their effective compounds against cancer. Journal of Pharmacognosy and Phytochemistry. 8(3). 827–833. 5 indexed citations
20.
Sarkar, Bishajit, et al.. (2019). Computational Assessment and Pharmacological Property Breakdown of Eight Patented and Candidate Drugs against Four Intended Targets in Alzheimer’s Disease. Advances in Bioscience and Biotechnology. 10(11). 405–430. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026